Shlomo Noy - Aug 15, 2024 Form 3 Insider Report for Biomotion Sciences (SLXN)

Signature
/s/ Mirit Horenshtein-Hadar, as attorney for Shlomo Noy
Stock symbol
SLXN
Transactions as of
Aug 15, 2024
Transactions value $
$0
Form type
3
Date filed
8/15/2024, 07:50 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SLXN Ordinary Shares 1.99M Aug 15, 2024 By Guangzhou Sino-Israel Biotech Fund F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person possesses shared voting and investment authority with respect to the shares reported in this line by virtue of his serving as Chief Medical Officer of Guangzhou Sino-Israel Biotech Fund ("GIBF"). The equity interests of GIBF are held by various individuals and entities. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his indirect pecuniary interest therein.